---
title: "Reviews — u-100 insulin syringes - Flapen"
canonical_url: "https://flapen.com/research/us/pet-supplies/u-100-insulin-syringes/reviews"
last_updated: "2026-07-21T21:04:42.228Z"
locale: en
meta:
  description: "Niche score 60/100 · $489K/yr market. A failed launch gate (market size, growth, or returns) keeps it on the watch list. Data updated Jul 2026."
  "og:description": "Niche score 60/100 · $489K/yr market. A failed launch gate (market size, growth, or returns) keeps it on the watch list. Data updated Jul 2026."
  "og:title": "Reviews — u-100 insulin syringes - Flapen"
---

# **u-100 insulin syringes**

**Worth a look**

Shows low returns (0.3%), but a failed launch gate (market size, growth, or returns) keeps it on the watch list.

Market size 59Growth 57Conversion 96Competition 34Returns 98Price range 59Avg price 79Brand share 44Review moat 63Quality gap 40

**Returns**

**Incredible****0.3%**

return rate — above 6% kills the launch gate

**Conversion**

**Incredible****13.3%**

search→purchase rate — share of searches ending in a sale

**Avg price**

**Great****$16.70**

avg listing price — sweet spot $15–$100

**Review moat**

**Good****975.41**

avg incumbent reviews — the moat a new listing must climb

**Market size**

**Good****$489K**

$489K/yr · 219K searches

**Price range**

**Good****$6.16–$27.87**

cheapest to priciest tracked listing — scored on the share inside $15–$100

**Growth**

**Good****+31.8%**

90-day search growth — must beat 0% to launch

**Brand share**

**Okay****79%**

top-5 brand share — brands hold most of the demand

**Quality gap**

**Okay****4.5★**

avg incumbent rating — lower means beatable quality

**Competition**

**Okay****65%**

top-5 click share — leaders hold, buyers still browse